about
Type 1 cytokine response and treatment outcome of genital HPV lesions.Prostate-specific membrane antigen-based therapeutics.X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.Attenuated Salmonella typhimurium with IL-2 gene reduces pulmonary metastases in murine osteosarcoma.NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity.Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12Antigen-independent activation of naive and memory resting T cells by a cytokine combination.Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration.Oscillatory IL-2 stimulus reveals pertinent signaling timescales of T cell responsiveness
P2860
Q32071286-81647723-F302-4AE4-941A-303F3278D81DQ35132944-16F24FFA-872D-4AF0-9F9D-DDE8052478FDQ35224827-6D8FEB14-473B-4C59-BED1-A22C2A8A3D87Q36657731-67FF5E2D-D3B4-499F-A5C7-B5C91A921BC4Q36702496-2C254D37-9223-417B-BA39-6FF1BDA36C10Q37340647-088EB002-8E3E-4BC4-8982-77432D4BABC0Q37680355-91742D71-1014-48EE-A4DA-162963C3EB88Q39630893-5AC8C0C0-4D50-4E16-A5BC-290D9C2EA4CDQ42942555-A08B15B5-21C7-4973-A094-12A5A902409CQ44038362-1257F27C-B230-482E-BD52-4CE7698D701EQ58727215-AABDC02C-E670-468E-AB22-CD1D39A79FCF
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Lowest dose interleukin-2 immunotherapy.
@en
type
label
Lowest dose interleukin-2 immunotherapy.
@en
prefLabel
Lowest dose interleukin-2 immunotherapy.
@en
P1433
P1476
Lowest dose interleukin-2 immunotherapy
@en
P2093
P304
P407
P577
1993-03-01T00:00:00Z